The purpose of this registry is to collect information on how the Zenflow Spring System works in everyday medical practice. The registry will track how the Spring System performs during the implant procedure, and at follow-up visits at 1, 3, 6, and 12 months. We will look at how symptoms improve, how quickly patients return to normal activities, how satisfied they are with treatment, and whether there are any problems or side effects related to the device.
Study Type
OBSERVATIONAL
Enrollment
300
Minimally Invasive Treatment for LUTS associated with BPH
Chopra Urology
Phoenix, Arizona, United States
NOT_YET_RECRUITINGSan Diego Clinical Trials
La Mesa, California, United States
RECRUITINGGulf Coast Clinical Trial Associates / Florida Urology Partners
Tampa, Florida, United States
RECRUITINGAvant Concierge Urology
Winter Garden, Florida, United States
RECRUITINGDr Slade Urology
Boise, Idaho, United States
ACTIVE_NOT_RECRUITINGThe Smith Institute of Urology/Northwell Health
Syosset, New York, United States
RECRUITINGSTART Research
Myrtle Beach, South Carolina, United States
ACTIVE_NOT_RECRUITINGMidtown Urology Associates
Austin, Texas, United States
RECRUITINGEffectiveness - IPSS
The primary effectiveness endpoint is the change in IPSS from baseline over time
Time frame: Baseline to 12 Months
Safety - adverse events
The primary safety endpoint is the observed rate of device-related serious adverse events (SAEs)
Time frame: Baseline to 12 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.